This is the authors' abstract. We don't add key points for this paper.
Recently, we reported on the design, synthesis, and structure-activity relationships of a series of spiroimidazolines endowed with alpha-adrenergic agonist activities. Among the compounds described, (R,S)-spiro(1,3-diazacyclopent-1-ene)-[5,2'](7'-methyl-1'2',3', 4',-tetrahydronaphthalene) fumarate (5RS) was chosen for further development as a venotonic agent. The resolution of this compound, as well as the pharmacological characterization of the enantiomers, stereospecific synthesis of eutomer (5S, S 18149), and determination of absolute configuration by single-crystal X-ray diffraction analysis, are described.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cordi et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: